OUTCOME OF THE BOARD MEETING HELD ON 31.07.2025 TO CONSIDER AND APPROVE : 1. Un-audited Financial Results of the Company for the quarter ended June 30, 2025 and the Auditors' Report thereon. 2. Gave their in-principal consent for the raising of funds through issue of equity shares on rights basis to the existing equity shareholders of the Company 1. Un-audited Financial Results of the Company for the quarter ended June 30, 2025 and the Auditors' Report thereon. 2. Gave their in-principal consent for the raising of funds through issue of equity shares on rights basis to the existing equity shareholders of the Company 3. Opening of a New Branch Office in Mumbai w.e.f. September 01, 2025.

pdf

Nexome Capital Markets Ltd.

28 Jul 2025

127.70

-1.08%

Company Update

Nexome Capital Markets Ltd - 508905 - Update On Reclassification Application

BSE India

Intimation of rejection of Reclassification Application

pdf

Nexome Capital Markets Ltd.

23 Jul 2025

127.70

-1.08%

Company Update

Nexome Capital Markets Ltd - 508905 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

We are forwarding copies of newspaper advertisement in respect of the notice of Board Meeting to be held on 31.07.2025 at 04:00 P.M. at the registered office of the Company published in English Daily Business Standard on Wednesday, 23.07.2025.

pdf

Nexome Capital Markets Ltd.

23 Jul 2025

127.70

-1.08%

Board Meeting

Nexome Capital Markets Ltd - 508905 - Board Meeting Intimation for Approval Of Un-Audited Financial Results …

BSE India

Nexome Capital Markets Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2025 ,inter alia, to consider and approve 1. Un-audited Financial Results for the quarter ended June 30, 2025. 2. Raising of funds pursuant to an issue of equity shares of the Company with a face value of ? 10 each (the 'Equity Shares') by way of a Rights Issue to the eligible equity shareholders of the Company, subject to the receipt of applicable regulatory/statutory approvals as may be required. 3. Any other matter, if required with the permission of the chair.

pdf

Is SMIFS Capital Markets Ltd. worth buying?

4 Votes:

Buy 75.0%

Sell 25.0%